SVB Leerink began coverage on shares of Ardent Health Partners (NYSE:ARDT – Free Report) in a research note published on Monday, MarketBeat.com reports. The brokerage issued an outperform rating and a $23.00 target price on the stock.
Separately, Truist Financial started coverage on shares of Ardent Health Partners in a research report on Monday. They issued a buy rating and a $21.00 price objective for the company. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of Buy and a consensus price target of $21.70.
Check Out Our Latest Analysis on Ardent Health Partners
Ardent Health Partners Trading Up 0.2 %
Ardent Health Partners Company Profile
We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.
Further Reading
- Five stocks we like better than Ardent Health Partners
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Brinker International’s Price Dip is an Appetizing Entry Point
- How to Evaluate a Stock Before Buying
- 3 Stocks That Could Beat the September Blues
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.
